This 2019 nested case-control study analyzed data from the QResearch and CPRD databases to assess the association between hormone replacement therapy (HRT) use and the risk of venous thromboembolism (VTE) in women aged 40–79. The study found that oral HRT, particularly combined estrogen-progestogen formulations, was associated with a significantly increased